Item Type | Name |
Academic Article
|
Motor, behavioral and pharmacologic findings in Tourette's syndrome.
|
Academic Article
|
Focal task-specific tremor and dystonia: categorization of occupational movement disorders.
|
Academic Article
|
Cranial-cervical dyskinesias: an overview.
|
Academic Article
|
Tetrabenazine therapy of dystonia, chorea, tics, and other dyskinesias.
|
Academic Article
|
Outcome after stereotactic thalamotomy for dystonia and hemiballismus.
|
Academic Article
|
Botulinum toxin in movement disorders.
|
Academic Article
|
Post-traumatic movement disorders: central and peripheral mechanisms.
|
Academic Article
|
Tardive stereotypy and other movement disorders in tardive dyskinesias.
|
Academic Article
|
Neuropsychological functioning in cortical-basal ganglionic degeneration: Differentiation from Alzheimer's disease.
|
Academic Article
|
Long-term effects of tetrabenazine in hyperkinetic movement disorders.
|
Academic Article
|
International Classification of Diseases, tenth revision: neurological adaptation (ICD-10 NA): extrapyramidal and movement disorders.
|
Academic Article
|
Delayed-onset progressive movement disorders after static brain lesions.
|
Academic Article
|
Tardive syndromes and other drug-induced movement disorders.
|
Academic Article
|
Unilateral thalamic deep brain stimulation for refractory essential tremor and Parkinson's disease tremor.
|
Academic Article
|
Tardive and idiopathic oromandibular dystonia: a clinical comparison.
|
Academic Article
|
Thalamic surgery for movement disorders.
|
Academic Article
|
Posteroventral medial pallidotomy for treatment of Parkinson's disease: preoperative magnetic resonance imaging features and clinical outcome.
|
Academic Article
|
Movement and reaction times and fine coordination tasks following pallidotomy.
|
Academic Article
|
Surgery for Parkinson disease and other movement disorders: benefits and limitations of ablation, stimulation, restoration, and radiation.
|
Academic Article
|
Evidence-based review of patient-reported outcomes with botulinum toxin type A.
|
Academic Article
|
Movement disorders in Friedreich's ataxia.
|
Academic Article
|
Neurologic approach to drug-induced movement disorders: a study of 125 patients.
|
Academic Article
|
Short and long-term motor and cognitive outcome of staged bilateral pallidotomy: a retrospective analysis.
|
Academic Article
|
Focal hand dystonia, mirror dystonia and motor overflow.
|
Academic Article
|
Botulinum toxin in clinical practice.
|
Academic Article
|
Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results.
|
Academic Article
|
Tardive dyskinesia and other movement disorders secondary to aripiprazole.
|
Academic Article
|
Rett syndrome and associated movement disorders.
|
Academic Article
|
Clinical application of botulinum toxin type B in movement disorders and autonomic symptoms.
|
Academic Article
|
Long-term prognosis of patients with psychogenic movement disorders.
|
Academic Article
|
Tetrabenazine for the treatment of chorea and other hyperkinetic movement disorders.
|
Academic Article
|
Human T-cell responses to botulinum neurotoxin. Responses in vitro of lymphocytes from patients with cervical dystonia and/or other movement disorders treated with BoNT/A or BoNT/B.
|
Academic Article
|
Movement disorders in autoimmune diseases.
|
Academic Article
|
The spectrum of movement disorders in children with anti-NMDA receptor encephalitis.
|
Academic Article
|
Drug Insight: from disturbed motility to disordered movement--a review of the clinical benefits and medicolegal risks of metoclopramide.
|
Academic Article
|
Comparison of Sinemet CR4 and standard Sinemet: double blind and long-term open trial in parkinsonian patients with fluctuations.
|
Academic Article
|
Lower body parkinsonism: evidence for vascular etiology.
|
Academic Article
|
Essential tremor: clinical correlates in 350 patients.
|
Academic Article
|
Parkinson's disease and movement disorders: moving forward.
|
Academic Article
|
Short-term and long-term safety of deep brain stimulation in the treatment of movement disorders.
|
Academic Article
|
Mozart's movements and behaviour: a case of Tourette's syndrome?
|
Academic Article
|
Mozart's movements and behaviour: a case of Tourette's syndrome?
|
Academic Article
|
Movement disorders. Preface.
|
Academic Article
|
Motor overflow and mirror dystonia.
|
Academic Article
|
Education research: patient telephone calls in a movement disorders center: lessons in physician-trainee education.
|
Academic Article
|
Alcohol in essential tremor and other movement disorders.
|
Academic Article
|
Dramatic response of facial stereotype/tic to tetrabenazine in the first reported cases of neuroferritinopathy in the United States.
|
Academic Article
|
Human T-cell responses to botulinum neurotoxin: proliferative responses in vitro of lymphocytes from botulinum neurotoxin A-treated movement disorder patients.
|
Academic Article
|
Lesch-Nyhan syndrome: a study of motor behavior and cerebrospinal fluid neurotransmitters.
|
Academic Article
|
Peripheral trauma and movement disorders: a systematic review of reported cases.
|
Academic Article
|
Tardive oculogyric crises.
|
Academic Article
|
Convergence spasm in conversion disorders: prevalence in psychogenic and other movement disorders compared with controls.
|
Academic Article
|
Reflexive and volitional saccades: biomarkers of Huntington disease severity and progression.
|
Academic Article
|
Metoclopramide-induced movement disorders. Clinical findings with a review of the literature.
|
Academic Article
|
Hemiballism-hemichorea. Clinical and pharmacologic findings in 21 patients.
|
Academic Article
|
Current concepts in Parkinson's disease and other movement disorders.
|
Academic Article
|
Deep brain stimulation hardware complications in patients with movement disorders: risk factors and clinical correlations.
|
Academic Article
|
How to identify tremor dominant and postural instability/gait difficulty groups with the movement disorder society unified Parkinson's disease rating scale: comparison with the unified Parkinson's disease rating scale.
|
Academic Article
|
Yips and other movement disorders in golfers.
|
Academic Article
|
Movement disorders in multiple sclerosis and other demyelinating diseases.
|
Academic Article
|
Movement disorders in cerebrovascular disease.
|
Academic Article
|
Hereditary motor-sensory neuropathy and movement disorders.
|
Academic Article
|
Cocaine-related movement disorders.
|
Academic Article
|
Assessment of motor function after stereotactic pallidotomy.
|
Academic Article
|
Post-traumatic movement disorders: effect of the legal system on outcome.
|
Academic Article
|
Treating severe bruxism with botulinum toxin.
|
Academic Article
|
Paroxysmal kinesigenic dyskinesias.
|
Academic Article
|
Psychogenic movement disorders: diagnosis and management.
|
Academic Article
|
The effect of deep brain stimulation on quality of life in movement disorders.
|
Academic Article
|
Tetrabenazine in the treatment of hyperkinetic movement disorders.
|
Academic Article
|
Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Process, format, and clinimetric testing plan.
|
Academic Article
|
Long-term tolerability of tetrabenazine in the treatment of hyperkinetic movement disorders.
|
Academic Article
|
Cervical dystonia: clinical findings and associated movement disorders.
|
Academic Article
|
Extrapyramidal involvement in Rett's syndrome.
|
Academic Article
|
Psychogenic movement disorders in children.
|
Academic Article
|
Movement disorders in musicians.
|
Academic Article
|
Peripherally induced movement disorders.
|
Academic Article
|
Treatment of hyperkinetic movement disorders.
|
Academic Article
|
Respiratory problems in neurologic movement disorders.
|
Academic Article
|
Transcutaneous electrical stimulation (TENS) for psychogenic movement disorders.
|
Academic Article
|
Iron dysregulation in movement disorders.
|
Academic Article
|
Analysis of CYP2D6 genotype and response to tetrabenazine.
|
Academic Article
|
Evidence-based review and assessment of botulinum neurotoxin for the treatment of movement disorders.
|
Concept
|
Movement
|
Concept
|
Stereotypic Movement Disorder
|
Concept
|
Movement Disorders
|
Concept
|
Eye Movements
|
Academic Article
|
Movement disorders in systemic lupus erythematosus and the antiphospholipid syndrome.
|
Academic Article
|
Restless legs syndrome and cerebrovascular disease - authors' reply.
|
Academic Article
|
Sensory aspects of movement disorders.
|
Academic Article
|
The clinical features of psychogenic movement disorders resembling tics.
|
Academic Article
|
Editorial: Neurotherapeutics of movement disorders.
|
Academic Article
|
Parkinson disease subtypes.
|
Academic Article
|
Alleviating manoeuvres (sensory tricks) in cervical dystonia.
|
Academic Article
|
"Psychogenic" versus "functional" movement disorders? That is the question.
|
Academic Article
|
Genetic movement disorders in patients of Jewish ancestry.
|
Academic Article
|
Movement disorders.
|
Academic Article
|
Paroxysmal movement disorders.
|
Academic Article
|
Psychogenic movement disorders.
|
Academic Article
|
Myorhythmia: phenomenology, etiology, and treatment.
|
Academic Article
|
The therapeutic potential of cannabinoids for movement disorders.
|
Academic Article
|
Movement disorders in catatonia.
|
Academic Article
|
Speech and voice disorders in patients with psychogenic movement disorders.
|
Academic Article
|
Leg stereotypy disorder.
|
Academic Article
|
Clinical and scientific perspectives on movement disorders: Stanley Fahn's contributions.
|
Academic Article
|
Movement Disorders From the Use of Metoclopramide and Other Antiemetics in the Treatment of Migraine.
|
Academic Article
|
Movement disorders induced by deep brain stimulation.
|
Academic Article
|
Parkinsonism, movement disorders and genetics in frontotemporal dementia.
|
Academic Article
|
Psychogenic Ophthalmologic Movement Disorders.
|
Academic Article
|
Dopamine depleters in the treatment of hyperkinetic movement disorders.
|
Academic Article
|
Examiner manoeuvres 'sensory tricks' in functional (psychogenic) movement disorders.
|
Academic Article
|
Understanding falls in progressive supranuclear palsy.
|
Academic Article
|
Movement disorders in 2016: Progress in Parkinson disease and other movement disorders.
|
Academic Article
|
ADCY5-related movement disorders: Frequency, disease course and phenotypic variability in a cohort of paediatric patients.
|
Academic Article
|
Botulinum toxin: State of the art.
|
Academic Article
|
Functional (psychogenic) stereotypies.
|
Academic Article
|
Autoimmune and paraneoplastic movement disorders: An update.
|
Academic Article
|
An update on new and unique uses of botulinum toxin in movement disorders.
|
Academic Article
|
Leg stereotypy syndrome: phenomenology and prevalence.
|
Academic Article
|
Treatable inherited rare movement disorders.
|
Academic Article
|
The Wide Spectrum of Functional Movement Disorders.
|
Grant
|
Clinical center for the study of neuroprotection from PD
|
Academic Article
|
Pathogenesis and pathophysiology of functional (psychogenic) movement disorders.
|
Academic Article
|
Psychogenic (Functional) Movement Disorders.
|
Academic Article
|
Are the International Parkinson disease and Movement Disorder Society progressive supranuclear palsy (IPMDS-PSP) diagnostic criteria accurate enough to differentiate common PSP phenotypes?
|
Academic Article
|
Functional gait disorders, clinical phenomenology, and classification.
|
Academic Article
|
Gender Differences in Functional Movement Disorders.
|
Academic Article
|
Treatment of Movement Disorders.
|
Academic Article
|
Reply to Gender Differences in Functional Movement Disorders: Sociocultural or Biological?
|
Academic Article
|
Expanding phenomenologic heterogeneity of tardive syndromes: Time for an updated assessment tool.
|
Academic Article
|
Botulinum Toxin in Movement Disorders: An Update.
|
Academic Article
|
Worldwide barriers to genetic testing for movement disorders.
|
Academic Article
|
Phenotypic Features of Isolated Essential Tremor, Essential Tremor Plus, and Essential Tremor-Parkinson's Disease in a Movement Disorders Clinic.
|
Academic Article
|
Beyond tics: movement disorders in patients with Tourette syndrome.
|
Academic Article
|
Editorial "Parkinsonism across the spectrum of movement disorders and beyond".
|
Academic Article
|
The Clinical Value of Patient Home Videos in Movement Disorders.
|
Academic Article
|
Increased Incidence of Functional (Psychogenic) Movement Disorders in Children and Adults Amid the COVID-19 Pandemic: A Cross-sectional Study.
|
Academic Article
|
Sports-Related Dystonia.
|
Academic Article
|
De novo variants in FRMD5 are associated with developmental delay, intellectual disability, ataxia, and abnormalities of eye movement.
|
Academic Article
|
COVID19-associated new-onset movement disorders: a follow-up study.
|
Academic Article
|
Driving Impairment in Movement Disorders.
|
Academic Article
|
Peripherally-induced Movement Disorders: An Update.
|
Academic Article
|
Current opinions and practices in post-stroke movement disorders: Survey of movement disorders society members.
|